Neutral
BioCryst appoints Charlie Gayer to succeed Jon Stonehouse as CEO
BioCryst Pharmaceuticals has appointed Charlie Gayer as its new CEO, succeeding Jon Stonehouse. Further details regarding this transition are expected...